Fig. 2From: Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLCAssessment of baseline blood counts in patients with NSCLC. Baseline ALCs (A), CD4 (B), CD8 (C) and CD4 plus CD8 (D) cell counts for different cohorts are illustrated. Bar represents mean and SD. P-values were tested by the Kruskal-Wallis testBack to article page